Cytotoxicity assessment of plant-produced immunogens.
journal contribution
posted on 2024-04-16, 17:35 authored by Martha M. O’Kennedy, Robyn Roth, Karen Ebersohn, Lissinda H. du Plessis, Sipho Mamputha, Daria A. Rutkowska, Ilse du Preez, Jan A. Verschoor, Yolandy LemmerCytotoxicity studies in Vero cells validating the (A) adjuvanted commercial vaccine, (B) VP2 proteins nonavalent (serotypes 1–9) combined versus plant extract, (C) plant produced VP2 proteins nonavalent (serotypes 1–9) combined and adjuvanted with Montanide Gel 01 or (D) plant produced VP2 proteins nonavalent (serotypes 1–9) combined and adjuvanted with Nanoalum. Statistical difference at P < 0.05 (indicated with a *) were considered significant in a two tailed Student’s t test.
(PDF)
History
Usage metrics
Keywords
β receptor knocksup >-/-produced ahs virusfirst interferon αdiv >< pantigenically distinguishable basedprovide compelling dataconfer protective immunitybased vaccine candidateahs vaccine industryhelper cells 2cell immune responses1 may play9 ahsv serotypesprime boost strategyexclusively vp2 ),adjuvanted nonavalent cocktailahsv ),protective efficacyelisa databoost vaccinationspecific serotypesadjuvanted ninevaccine candidatesvaccine administeredcommercial vaccinevp2 combinationvalent formulationstwo pentavalenttarget animalspreviously demonstratednonavalent vp2nine serotypesmultivalent primemediated memorylocalised outbreakslike particlesimmunogenic profileequally wellendemic countries
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC